Knowledge Center

Presentation / Sep 10, 2015

Screening methodologies to expedite the formulation development of amorphous solid dispersions

Authors:
  • Iris Duarte
  • João Henriques
  • João F. Pinto
  • Marcio Temtem
Source:
2015 APS Presentation, Íris Duarte

Related links

2015 APS Presentation - Screening methodologies

Also in the Knowledge Center

Related Content

History of Hovione

Hovione was established in Portugal in 1959 by Ivan Villax with his wife, Diane Villax, and two other Hungarian refugees: Nicholas de Horthy and Andrew Onody, thus forming the name HOVIONE.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Membrane Technology

Hovione has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more